Recombinant Bacillus subtilis SPBc2 prophage-derived protein BhlB (bhlB)

Shipped with Ice Packs
In Stock

Description

Molecular and Functional Overview

BhlB is encoded by the bhlB gene (synonyms: yomA, BSU21430) within the SPBc2 prophage genome . SPBc2 is a temperate bacteriophage that integrates into the B. subtilis chromosome during lysogeny and can enter the lytic cycle under stress . The protein is classified as a holin-like bacteriophage protein, suggesting involvement in host cell lysis—a critical step for phage progeny release .

Key Features:

PropertyDetails
Gene LocationSPBc2 prophage genome (BSU21430 locus in B. subtilis 168)
Protein Length88 amino acids (recombinant form, residues 1-88)
Molecular FunctionHolin-like activity; facilitates phage-induced host lysis
UniProt IDO31984

Role in SPBc2 Phage Biology

  • Integration Site: SPBc2 prophage integrates into the B. subtilis chromosome at the spsM gene, reconstituting it upon excision during sporulation or phage induction .

  • Lytic Cycle Activation: BhlB’s holin-like function likely contributes to host membrane disruption, enabling phage release .

Experimental Uses

  • ELISA: Recombinant BhlB is used in immunoassays to study antibody interactions .

  • Structural Studies: Full-length or truncated variants aid in crystallography or functional domain mapping .

Research Implications

The study of BhlB provides insights into:

  1. Phage-Host Dynamics: Mechanisms of lysis/lysogeny decisions in B. subtilis .

  2. Protein Engineering: Optimization of recombinant production for industrial or therapeutic phage applications.

Product Specs

Form
Lyophilized powder
Please note: We prioritize shipping the format currently in stock. However, if you have specific format requirements, please indicate them in your order notes. We will fulfill your request to the best of our ability.
Lead Time
Delivery time may vary based on the purchasing method and location. Please contact your local distributor for specific delivery timeframes.
Note: All of our proteins are shipped with standard blue ice packs. If you require dry ice shipping, please inform us in advance as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. For optimal results, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents are at the bottom. Reconstitute the protein in deionized sterile water to a final concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50%, which can be used as a reference.
Shelf Life
The shelf life of our products is influenced by various factors including storage conditions, buffer composition, temperature, and the protein's intrinsic stability.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type is determined during production. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
bhlB; yomA; BSU21430; SPbeta prophage-derived protein BhlB
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-88
Protein Length
full length protein
Species
Bacillus subtilis (strain 168)
Target Names
bhlB
Target Protein Sequence
MFENIDKGTIVRTLLLAIALLNQIMVMLGKAAFIINEEDINHLYDCLYTIFTIVFTTSTT TAAWFKNNYITAKGKKQKQVLKKENLFK
Uniprot No.

Target Background

Function
BhlB, a prophage-derived protein from Bacillus subtilis, may play a role in the secretion of the autolysin BlyA.
Database Links
Protein Families
SPP1 holin family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is Bacillus subtilis SPBc2 prophage-derived protein BhlB and what is its significance in research?

Bacillus subtilis SPBc2 prophage-derived protein BhlB is a protein encoded within the SPBc2 prophage region of the B. subtilis genome. Prophages are viral genomes integrated into bacterial chromosomes, and their encoded proteins often play roles in bacterial physiology, phage lifecycle regulation, or host-phage interactions. B. subtilis is widely used in research and industry for its food safety properties and as a model organism for studying gram-positive bacteria .

To characterize bhlB, researchers should employ a multifaceted approach including:

  • Sequence analysis to identify conserved domains and motifs

  • Expression analysis under various physiological conditions

  • Knockout studies to determine phenotypic effects

  • Interaction studies with other bacterial or phage proteins

The protein may be involved in regulating bacterial metabolism during lysogeny or participating in the switch between lysogenic and lytic cycles, making it valuable for understanding prophage-host dynamics.

How does the SPBc2 prophage region containing the bhlB gene differ from other prophages in B. subtilis?

The SPBc2 prophage represents one of several prophage elements in the B. subtilis genome. To differentiate SPBc2 from other prophages, researchers should implement:

  • Comparative genomic analysis:

    • Alignment of the SPBc2 genomic region with other B. subtilis prophages

    • Identification of unique genetic elements and gene arrangements

    • Analysis of GC content and codon usage patterns

  • Transcriptional profiling:

    • RNA-seq analysis under various conditions to determine differential expression patterns

    • Identification of SPBc2-specific promoters and regulatory elements

  • Induction behavior analysis:

    • Comparison of induction triggers between SPBc2 and other prophages

    • Measurement of induction kinetics and efficiency

SPBc2 prophage genes, including bhlB, may exhibit different expression patterns compared to other prophage regions, potentially indicating specialized functions in bacterial physiology or phage biology.

What experimental evidence confirms the presence and expression of bhlB in B. subtilis strains?

Confirmation of bhlB presence and expression requires multiple lines of evidence:

  • Genomic detection:

    • PCR amplification using bhlB-specific primers

    • Southern blotting to confirm genomic integration

    • Whole genome sequencing and annotation

  • Transcriptional evidence:

    • RT-PCR to detect bhlB mRNA

    • RNA-seq to quantify expression levels under different conditions

    • 5' RACE to map transcription start sites

  • Protein detection:

    • Western blotting using antibodies against bhlB

    • Mass spectrometry to identify bhlB peptides in cellular extracts

    • Immunofluorescence microscopy to localize the protein within bacterial cells

Expression patterns may vary depending on growth phase, stress conditions, or external stimuli, requiring careful experimental design and appropriate controls.

What expression systems are optimal for recombinant bhlB production?

The choice of expression system significantly impacts yield and functionality of recombinant bhlB:

  • Homologous expression in B. subtilis:

    • Advantages: Native cellular environment, proper folding, potential for correct post-translational modifications

    • Implementation: Clone bhlB into B. subtilis expression vectors with inducible promoters (e.g., IPTG-inducible Pspac)

    • Optimization parameters: Induction timing, temperature (25-37°C), media composition

  • Heterologous expression in E. coli:

    • Advantages: Higher yields, established protocols, ease of genetic manipulation

    • Implementation: Clone into pET vectors for expression in E. coli BL21(DE3) or similar strains

    • Considerations: Codon optimization may be necessary to account for different codon usage patterns

  • Cell-free expression systems:

    • Application: Useful for initial characterization or when the protein exhibits toxicity in vivo

    • Implementation: Commercial cell-free expression kits based on E. coli or wheat germ extracts

    • Limitations: Typically lower yield but rapid production

For each system, optimizing parameters such as induction time, temperature, and media composition is critical for maximizing soluble protein yield.

What purification strategies yield the highest purity of recombinant bhlB?

A systematic purification strategy for bhlB should include:

  • Initial capture:

    • Affinity chromatography (IMAC for His-tagged bhlB or other appropriate affinity tags)

    • Buffer conditions: pH 7.5-8.0, 300-500 mM NaCl, 5-10% glycerol to maintain stability

  • Intermediate purification:

    • Ion exchange chromatography based on predicted isoelectric point

    • Size exclusion chromatography to separate monomeric bhlB from aggregates

  • Quality assessment:

    • SDS-PAGE with Coomassie staining (>95% purity target)

    • Western blotting for specific detection

    • Mass spectrometry for accurate molecular weight and post-translational modification analysis

Purification StepMethodBuffer CompositionExpected YieldPurity
Cell LysisSonication or French Press50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol, 1 mM PMSF100% (reference)1-5%
Affinity ChromatographyIMAC (Ni-NTA)50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol, 10-250 mM imidazole60-70%70-80%
Size ExclusionSuperdex 20020 mM Tris-HCl pH 7.5, 150 mM NaCl, 5% glycerol40-50%>95%

Optimization of each step should consider bhlB's predicted properties including molecular weight, isoelectric point, and hydrophobicity.

How can researchers verify the structural integrity of purified recombinant bhlB?

Verification of bhlB structural integrity requires multiple complementary techniques:

  • Biophysical characterization:

    • Circular Dichroism (CD) spectroscopy to assess secondary structure content

    • Differential Scanning Fluorimetry (DSF) to determine thermal stability

    • Dynamic Light Scattering (DLS) to confirm monodispersity and absence of aggregation

  • Functional verification:

    • Develop activity assays based on predicted functions (DNA binding, protein-protein interactions)

    • Compare activities of different preparations to establish consistency

    • Include positive controls (if available) for quantitative comparison

  • Structural analysis:

    • Limited proteolysis to assess domain organization and folding

    • Native PAGE to evaluate oligomeric state

    • Small-angle X-ray scattering (SAXS) for low-resolution structural information

Parameters to measure and report include melting temperature (Tm), secondary structure composition percentages, hydrodynamic radius, and specific activity units.

What techniques can determine bhlB protein interactions with bacterial or phage components?

Identifying protein interaction partners is crucial for understanding bhlB function:

  • Affinity-based approaches:

    • Co-immunoprecipitation with anti-bhlB antibodies

    • Pull-down assays using tagged recombinant bhlB

    • Crosslinking followed by mass spectrometry (XL-MS)

  • Library screening methods:

    • Bacterial two-hybrid screening against B. subtilis genomic libraries

    • Phage display to identify peptide motifs interacting with bhlB

    • Protein microarrays containing B. subtilis proteome

  • Biophysical interaction analysis:

    • Surface Plasmon Resonance (SPR) for determining binding kinetics

    • Isothermal Titration Calorimetry (ITC) for thermodynamic parameters

    • Microscale Thermophoresis (MST) for binding affinity in solution

  • In vivo validation:

    • Fluorescence resonance energy transfer (FRET) with fluorescently tagged proteins

    • Bimolecular fluorescence complementation (BiFC) for visualizing interactions in live cells

Data should be presented as a network of interactions with quantitative parameters (Kd values, association/dissociation rates) where applicable.

How can researchers assess the impact of bhlB on B. subtilis physiology and phage lifecycle?

A comprehensive assessment requires multiple phenotypic analyses:

  • Genetic manipulation approaches:

    • Generate bhlB deletion mutant using CRISPR-Cas9 or traditional homologous recombination

    • Create conditional expression strains using inducible promoters

    • Construct point mutations in predicted functional domains

  • Physiological analysis:

    • Growth curves under various conditions (different media, stress factors)

    • Biofilm formation assays

    • Sporulation efficiency measurements

    • Metabolic profiling using LC-MS or NMR

  • Phage-related phenotypes:

    • Prophage induction frequency with and without bhlB

    • Phage production and burst size measurements

    • Lysogenic conversion properties

    • Superinfection immunity testing

  • Global impact assessment:

    • Transcriptomic analysis (RNA-seq) comparing wild-type and bhlB mutant strains

    • Proteomic profiling to identify pathways affected by bhlB expression

Results should be quantified and statistically analyzed to determine the significance of observed differences.

What DNA-binding properties might bhlB exhibit and how can they be characterized?

If bhlB functions as a DNA-binding protein, characterize its properties through:

  • In vitro DNA binding assays:

    • Electrophoretic Mobility Shift Assay (EMSA) with labeled DNA fragments

    • DNase I footprinting to identify protected sequences

    • Chromatin Immunoprecipitation (ChIP) followed by sequencing (ChIP-seq)

  • Binding specificity determination:

    • Systematic Evolution of Ligands by Exponential Enrichment (SELEX)

    • Protein-Binding Microarrays (PBMs) with various DNA sequences

    • Competition assays with specific and non-specific DNA sequences

  • Structural basis of DNA binding:

    • Identify DNA-binding motifs through sequence analysis and mutagenesis

    • X-ray crystallography or NMR of bhlB-DNA complexes

    • Molecular dynamics simulations to model binding mechanisms

Report binding affinities (Kd values), specificity indices, and consensus binding sequences with appropriate statistical validation.

How does bhlB potentially contribute to prophage-mediated horizontal gene transfer in bacterial communities?

Prophage-encoded proteins can facilitate genetic exchange between bacteria. To investigate bhlB's role:

  • Transfer frequency analysis:

    • Measure horizontal gene transfer rates in wild-type vs. bhlB mutant strains

    • Quantify transduction frequencies using antibiotic resistance markers

    • Monitor transfer of mobile genetic elements in mixed bacterial populations

  • Molecular mechanism investigation:

    • Test if bhlB binds to specific DNA sequences involved in packaging or transfer

    • Examine interaction with other proteins involved in DNA mobilization

    • Assess impact on recombination frequency and specificity

  • Ecological significance assessment:

    • Analyze transfer dynamics in simulated natural environments

    • Measure competitive fitness of strains with and without functional bhlB

    • Evaluate transfer under different stress conditions relevant to natural habitats

Data should be presented as transfer frequencies per recipient cell with appropriate statistical analysis across multiple experimental replicates.

What role might bhlB play in bacterial stress responses and antibiotic resistance?

Prophage genes often contribute to stress adaptation. For bhlB:

  • Stress response characterization:

    • Compare survival of wild-type and bhlB mutant under various stressors (oxidative, pH, temperature, osmotic)

    • Monitor bhlB expression using reporter fusions under stress conditions

    • Identify stress-response pathways affected by bhlB through transcriptomics

  • Antibiotic resistance assessment:

    • Determine Minimum Inhibitory Concentrations (MICs) for various antibiotics

    • Measure persister cell formation frequency

    • Analyze biofilm resistance properties with and without bhlB

  • Mechanistic studies:

    • Identify potential bhlB interactions with stress-response regulators

    • Examine impact on membrane integrity and efflux pump activity

    • Investigate effects on cell wall composition and synthesis

Results should include quantitative measurements of survival rates, gene expression levels, and antibiotic susceptibility with appropriate controls and replicates.

How can structural biology approaches advance understanding of bhlB function?

Structural characterization provides mechanistic insights:

  • High-resolution structure determination:

    • X-ray crystallography of purified bhlB (alone and in complexes)

    • Cryo-electron microscopy for larger assemblies

    • NMR spectroscopy for dynamic regions and smaller domains

  • Structural dynamics:

    • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map flexible regions

    • Single-molecule FRET to observe conformational changes

    • Molecular dynamics simulations to predict functional motions

  • Structure-guided functional studies:

    • Site-directed mutagenesis of key residues identified in structures

    • Domain deletion or swapping experiments

    • Design of structure-based inhibitors or activators

The resulting structural data should be deposited in the Protein Data Bank (PDB) with comprehensive analyses of functional implications.

How can researchers overcome poor expression or insolubility of recombinant bhlB?

Addressing expression and solubility issues requires systematic optimization:

  • Expression enhancement strategies:

    • Test multiple expression vectors with different promoter strengths

    • Optimize codon usage for the expression host

    • Screen various induction parameters (temperature: 18-37°C, inducer concentration, induction time)

    • Evaluate different cell densities at induction (OD600: 0.4-1.0)

  • Solubility improvement approaches:

    • Fusion with solubility-enhancing tags (MBP, SUMO, GST, TrxA)

    • Co-expression with molecular chaperones (GroEL/GroES, DnaK/DnaJ/GrpE)

    • Addition of solubility enhancers to lysis buffer (arginine, sorbitol, non-detergent sulfobetaines)

    • Expression at reduced temperatures (16-25°C)

  • Domain-based strategies:

    • Bioinformatic identification of structured domains for separate expression

    • Removal of predicted hydrophobic or aggregation-prone regions

    • Design of synthetic constructs with optimized solubility properties

Optimization StrategyImplementationExpected OutcomeSuccess Indicators
Temperature ReductionExpress at 18°C for 16-20hSlower folding, less aggregation2-5× increase in soluble fraction
Fusion TagsN-terminal MBP or SUMO fusionEnhanced solubility3-10× increase in soluble protein
Chaperone Co-expressionCo-transform with chaperone plasmidsAssisted folding2-4× increase in functional protein
Buffer OptimizationScreen additives (5-10% glycerol, 0.1-0.5M arginine)Stabilized native stateReduced aggregation during purification

Implement these strategies systematically, documenting outcomes at each step.

What are the best approaches to validate bhlB knockout phenotypes and avoid misinterpretation?

Rigorous validation ensures reliable phenotypic data:

  • Multiple knockout strain construction:

    • Create knockouts using at least two independent methods (allelic replacement, CRISPR-Cas9)

    • Generate marker-free deletions to avoid polar effects

    • Include nonsense mutations as alternatives to complete gene deletion

  • Complementation tests:

    • Express bhlB from ectopic loci or plasmids in knockout strains

    • Use inducible promoters to titrate expression levels

    • Include both native and tagged versions for functional verification

  • Control experiments:

    • Compare to knockout strains of adjacent genes to rule out regional effects

    • Perform whole genome sequencing to confirm absence of secondary mutations

    • Include positive and negative controls in all phenotypic assays

  • Quantitative analysis:

    • Employ statistical methods appropriate for the data type (t-tests, ANOVA)

    • Ensure sufficient biological replicates (minimum n=3)

    • Present data with appropriate error bars and significance indicators

How can transcriptomics and proteomics be applied to understand bhlB regulatory networks?

Multi-omics approaches provide system-level insights:

  • Transcriptomic analysis:

    • RNA-seq comparing wild-type and bhlB mutant strains under different conditions

    • Time-course analysis during prophage induction

    • Single-cell RNA-seq to capture population heterogeneity

    • Implementation method: Extract total RNA, deplete rRNA, prepare libraries for Illumina sequencing

  • Proteomic approaches:

    • Label-free quantitative proteomics comparing protein abundances

    • Phosphoproteomics to identify signaling pathways affected by bhlB

    • Protein turnover analysis using pulse-chase with stable isotopes

    • Implementation method: LC-MS/MS with appropriate fractionation methods

  • Integrative analysis:

    • Correlation of transcriptomic and proteomic datasets

    • Network analysis to identify regulatory hubs

    • Pathway enrichment analysis for affected biological processes

  • Validation experiments:

    • Quantitative PCR for selected genes

    • Western blotting for key proteins

    • Reporter gene fusions to confirm regulatory relationships

Data should be analyzed using appropriate statistical methods and visualization tools (heat maps, volcano plots, network diagrams).

What approaches can resolve contradictory findings about bhlB function in different experimental systems?

Addressing contradictory results requires systematic investigation:

  • Strain-specific factors:

    • Compare bhlB sequences across strains for polymorphisms

    • Analyze genetic background differences that might influence phenotypes

    • Perform cross-complementation experiments between strains

  • Methodological variance:

    • Standardize experimental protocols across laboratories

    • Control environmental parameters (media composition, growth conditions)

    • Use multiple methods to measure the same phenotype

  • Context-dependent function:

    • Test hypotheses under various physiological states

    • Examine interactions with strain-specific factors

    • Investigate condition-specific regulatory mechanisms

  • Meta-analysis approach:

    • Systematically compare experimental designs across studies

    • Identify variables that correlate with observed differences

    • Develop unified models that incorporate context-dependence

Present findings as a decision tree or conditional model that accounts for when and why different functions are observed under specific conditions.

How might CRISPR-Cas9 techniques advance functional studies of bhlB in B. subtilis?

CRISPR-Cas9 offers powerful approaches for precise genetic manipulation:

  • Genome editing applications:

    • Generation of scarless deletions or point mutations in bhlB

    • Introduction of epitope tags or fluorescent protein fusions at native loci

    • Creation of conditional alleles through insertion of inducible elements

    • Implementation protocol: Design sgRNAs targeting bhlB with appropriate PAM sites, provide repair templates with desired modifications

  • Gene regulation approaches:

    • CRISPRi (CRISPR interference) using dCas9 for tunable repression

    • CRISPRa (CRISPR activation) for enhanced expression

    • Timing-controlled activation/repression with inducible Cas9 variants

    • Implementation protocol: Express dCas9 fusions and sgRNAs targeting the bhlB promoter region

  • High-throughput screening:

    • Creation of sgRNA libraries targeting bhlB domains

    • Pooled screens to identify functional regions

    • Synthetic genetic array analysis with CRISPR-based mutations

  • In vivo tracking:

    • CRISPR-based imaging of genomic loci associated with bhlB

    • Monitoring dynamic changes during prophage induction

    • Visualization of chromosome reorganization events

Document efficiency metrics for each application, including editing efficiency, specificity scores, and phenotypic penetrance.

What are the potential applications of bhlB in synthetic biology and biotechnology?

Prophage proteins have untapped biotechnological potential:

  • Bioproduction applications:

    • Engineering bhlB as a regulator for controlled gene expression

    • Development of bhlB-based biosensors for specific stimuli

    • Incorporation into synthetic circuits for programmed cellular behaviors

    • Design considerations: Characterize input-output relationships, dynamic range, and orthogonality

  • Antimicrobial development:

    • Exploration of bhlB as a target for phage-inspired antimicrobials

    • Engineering phage-derived systems with bhlB components

    • Creation of selective growth inhibitors based on bhlB mechanisms

    • Testing protocol: Determine specificity, efficacy, and resistance development frequency

  • Industrial applications:

    • Evaluation of bhlB's potential in improving B. subtilis as a cell factory

    • Investigation of stress resistance properties for industrial strain improvement

    • Development of controlled lysis systems for product release

    • Implementation strategy: Integrate with existing B. subtilis chassis optimization approaches

  • Research tools:

    • Development of bhlB-based molecular switches

    • Creation of inducible recombination systems

    • Design of orthogonal regulatory elements for synthetic biology

Each application should be evaluated for efficiency, specificity, scalability, and economic feasibility compared to existing alternatives.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.